scholarly journals AAA 34. Endovascular Approach Replacing Surgical Repair for Aortoiliac Occlusive Disease

2019 ◽  
Vol 70 (5) ◽  
pp. e146
Author(s):  
Tamer Tamimi ◽  
Menachem Najman ◽  
Jakob Nowotny ◽  
Ralf Kolvenbach ◽  
Ron Karmeli
Keyword(s):  
Surgical Repair ◽  
Occlusive Disease ◽  
Aortoiliac Occlusive Disease ◽  
Endovascular Approach

Endovascular Approach Versus Aortobifemoral Bypass Grafting: Outcomes in Extensive Aortoiliac Occlusive Disease

2019 ◽  
Vol 54 (2) ◽  
pp. 102-110 ◽  
Author(s):  
João Rocha-Neves ◽  
André Ferreira ◽  
Joel Sousa ◽  
António Pereira-Neves ◽  
José Vidoedo ◽  
...  
Keyword(s):  
Open Surgery ◽  
Common Femoral Artery ◽  
Occlusive Disease ◽  
Aortobifemoral Bypass ◽  
Aortoiliac Occlusive Disease ◽  
Type D ◽  
Procedure Cost ◽  
History Of ◽  
Endovascular Approach ◽  
Cost Efficient

Objective: Compare technical, clinical, and economic outcomes between endovascular and open approaches in patients with type D aortoiliac occlusive disease according to the TransAtlantic Inter-Society Consensus. Methods: Patients undergoing revascularization for type D aortoiliac lesions, either endovascular or open surgery approach, from 2 Portuguese institutions between January 2011 and October 2017 were included. The surgical technique was left to the surgeon discretion. Patients with common femoral artery affection, both obstructive and aneurysmatic, were excluded. Results: Twenty-seven patients underwent aortobifemoral bypass and 32 patients were submitted to endovascular repair. The patients undergoing endovascular procedure were more likely to present with chronic heart failure ( P = .001) and chronic kidney disease ( P = .022) and less likely to have a history of smoking ( P = .05). The mean follow-up period was 67.84 (95% confidence interval = 61.85-73.83) months. The open surgery approach resulted in a higher technical success ( P = .001); however, limb salvage and patency rates were not different between groups. Endovascular approach was associated with a shorter length-of-stay, both inpatient (6 vs 9 days; P = .041) and patients admitted in the intensive care unit (0 vs 3.81 days; P = .001) as well as lower hospital expenses (US$9281 vs US$23 038; P = .001) with a similar procedure cost (US$2316 vs US$1173; P = .6). No differences were found in the postsurgical quality of life. Conclusion: Endovascular approach is, at least, clinically equivalent to open surgery approach and is more cost-efficient. The “endovascular-first” approach should be considered for type D occlusive aortoiliac lesions.

scholarly journals Endovascular Surgery or Both: A Case Report of Hybrid Procedure in a Patient with Abdominal Aortic Aneurysm and Tasc D Aortoiliac Occlusive Disease

2020 ◽  
Vol 14 (1) ◽  
pp. 48-51
Author(s):  
Sidhi Laksono Purwowiyoto ◽  
R. Mohammad Reza Juniery Pasciolly ◽  
Ananta Siddhi Prawara
Keyword(s):  
Abdominal Aortic Aneurysm ◽  
Aortic Aneurysm ◽  
Hybrid Procedure ◽  
Occlusive Disease ◽  
Vascular Surgeon ◽  
Aortoiliac Occlusive Disease ◽  
Abdominal Aortic ◽  
Endovascular Approach ◽  
Open Surgical Approach

Hybrid procedure, a combination of endovascular and open surgical approach, has emerged as the first-line treatment for patients with severe aortoiliac diseases because of its effectiveness. We report a hybrid procedure in a 72 year old man with an Abdominal Aortic Aneurysm (AAA) and Trans-Atlantic Inter-Society Consensus (TASC) D aortoiliac occlusive disease. After two failed attempts using the intraluminal technique (retrograde and antegrade), we successfully performed an endovascular approach with subintimal and Subintimal Arterial Flossing Antegrade-retrograde Intervention (SAFARI) technique with the help of roadmap technology. The vascular surgeon completed the procedure by creating femorofemoral bypass using a Great Saphenous Vein (GSV) graft. The graft was patent and there were no complications at 1 week, 1 month and 6 months follow-up.

Transbrachial and transfemoral approaches combined with visceral protection for the treatment of juxtarenal aortoiliac occlusive disease: Technical issues and clinical outcomes

Vascular ◽  
2021 ◽  
pp. 170853812110232
Author(s):  
Peixian Gao ◽  
Changliang Li ◽  
Xuejun Wu ◽  
Gang Li ◽  
Dianning Dong ◽  
...  
Keyword(s):  
Endovascular Treatment ◽  
Bare Metal Stents ◽  
Covered Stent ◽  
Occlusive Disease ◽  
Metal Stents ◽  
Infrarenal Aorta ◽  
Bare Metal ◽  
Stent Grafts ◽  
Aortoiliac Occlusive Disease

Purpose To evaluate the safety and efficacy of transbrachial and transfemoral approaches combined with visceral protection for the endovascular treatment of juxtarenal aortoiliac occlusive disease (AIOD) over an average 19-month follow-up period. Methods In this retrospective analysis, all patients with juxtarenal AIOD at a single institution were reviewed from June 2015 to January 2020. Patient characteristics, angiographic results, and follow-up outcomes were retrospectively recorded. The indications for treatment were critical limb threatening ischemia in 12 patients and bilateral claudication in five patients. Percutaneous access via the left brachial artery was first obtained to recanalize the infrarenal occluded lesions. After that, femoral accesses were achieved. A 4-Fr catheter, a 4 mm balloon, or a 6-Fr 90-cm-long sheath was used to complete visceral artery protection. Results A total of 17 juxtarenal AIOD patients (14 males; mean age, 63.4 ± 8.1 years) underwent endovascular treatment. The technical success rate was 100%. Complete reconstruction was achieved in 15 (88.2%) patients. The infrarenal aorta was reconstructed with kissing covered stent grafts ( n = 7), kissing bare-metal stents ( n = 2), covered stent grafts ( n = 2), bare-metal stents ( n = 1), or the off-label use of iliac limb stent grafts ( n = 5). Renal embolization was found in 3 (17.6%) patients during intraoperative angiography. There was 1 (5.9%) case of distal runoff embolization after CDT and 1 (5.9%) case of left iliac artery rupture. One (5.9%) death occurred due to acute myocardial infarction 20 days after the operation. The average follow-up period was 19.3 ± 16.7 months (range, 1–54 months) in the remaining 16 cases. The renal artery patency rate was 100%. The estimated cumulative primary patency rates were 92.3% at 12 months and 59.3% at 36 months according to the Kaplan–Meier method. Conclusions Transbrachial and transfemoral approaches combined with visceral protection offer a safe and effective alternative to open revascularization for the endovascular treatment of juxtarenal AIOD.

Effect of conservative treatment in aortoiliac occlusive disease

2019 ◽  
Vol 120 (4) ◽  
pp. 231-237
Author(s):  
W. Wen ◽  
G. H. Ho ◽  
E. J. Veen ◽  
H. G. W. de Groot ◽  
M. G. Buimer ◽  
...  
Keyword(s):  
Conservative Treatment ◽  
Occlusive Disease ◽  
Aortoiliac Occlusive Disease

scholarly journals Hemodynamic comparison of stent configurations used for aortoiliac occlusive disease

2017 ◽  
Vol 66 (1) ◽  
pp. 251-260.e1 ◽  
Author(s):  
Erik Groot Jebbink ◽  
Varghese Mathai ◽  
Johannes T. Boersen ◽  
Chao Sun ◽  
Cornelis H. Slump ◽  
...  
Keyword(s):  
Occlusive Disease ◽  
Aortoiliac Occlusive Disease

Outcomes of hypogastric coverage and occlusion during endovascular treatment of aortoiliac occlusive disease

2021 ◽  
Author(s):  
Andrew H. Smith ◽  
Siddhartha Dash ◽  
Erin C. Driscoll ◽  
Levester Kirksey ◽  
Jarrad Rowse ◽  
...  
Keyword(s):  
Endovascular Treatment ◽  
Occlusive Disease ◽  
Aortoiliac Occlusive Disease

scholarly journals Endovascular treatment of TransAtlantic Inter-Society Consensus D aortoiliac occlusive disease using unibody bifurcated endografts

2017 ◽  
Vol 65 (2) ◽  
pp. 398-405 ◽  
Author(s):  
Robert M. Van Haren ◽  
Lee J. Goldstein ◽  
Omaida C. Velazquez ◽  
Jagajan Karmacharya ◽  
Arash Bornak
Keyword(s):  
Endovascular Treatment ◽  
Occlusive Disease ◽  
Aortoiliac Occlusive Disease
Sign in / Sign up

Export Citation Format

Share Document